Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers - Wikidata - awgldk - TriplyDB

Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers

Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers

http://www.wikidata.org/entity/Q36368804

about

Microbial exposure during early life has persistent effects on natural killer T cell function The role of NKT cells in tumor immunity The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions How do natural killer T cells help B cells?Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids NKT cell subsets as key participants in liver physiology and pathology Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?Immunoregulation of NKT Cells in Systemic Lupus Erythematosus CD8⁺ T Cell-Independent Immune-Mediated Mechanisms of Anti-Tumor Activity CD1d- and MR1-Restricted T Cells in Sepsis The Extended Family of CD1d-Restricted NKT Cells: Sifting through a Mixed Bag of TCRs, Antigens, and Functions Imaging of NKT Cell Recirculation and Tissue Migration during Antimicrobial Immunity Turned on by danger: activation of CD1d-restricted invariant natural killer T cells Ly49 receptors: innate and adaptive immune paradigms CD1 and mycobacterial lipids activate human T cells The functions of type I and type II natural killer T cells in inflammatory bowel diseases NKT cell networks in the regulation of tumor immunity The regulatory role of invariant NKT cells in tumor immunity Activation of invariant NKT cells exacerbates experimental visceral leishmaniasis Differential Recognition of CD1d-α-Galactosyl Ceramide by the Vβ8.2 and Vβ7 Semi-invariant NKT T Cell Receptors Mechanisms for Glycolipid Antigen-Driven Cytokine Polarization by V 14i NKT Cells A Molecular Basis for the Exquisite CD1d-Restricted Antigen Specificity and Functional Responses of Natural Killer T Cells A Molecular Basis for NKT Cell Recognition of CD1d-Self-Antigen Cardiolipin Binds to CD1d and Stimulates CD1d-Restricted T Cells in the Normal Murine Repertoire Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells CD1d-lipid antigen recognition by the γδ TCR Intravital imaging - dynamic insights into natural killer T cell biology T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A The adaptor protein AP-3 is required for CD1d-mediated antigen presentation of glycosphingolipids and development of Valpha14i NKT cells Analysis of the CD1 antigen presenting system in humanized SCID mice Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance Invariant natural killer T cells act as an extravascular cytotoxic barrier for joint-invading Lyme Borrelia.Liver inflammation in a mouse model of Th1 hepatitis despite the absence of invariant NKT cells or the Th1 chemokine receptors CXCR3 and CCR5.miR-150 regulates the development of NK and iNKT cells.Toll-like receptor 3 ligand dampens liver inflammation by stimulating Valpha 14 invariant natural killer T cells to negatively regulate gammadeltaT cells.V(alpha)14iNKT cells promote liver pathology during adenovirus infection by inducing CCL5 production: implications for gene therapy.CD8(+)NKT-like cells regulate the immune response by killing antigen-bearing DCs.Modulation of NKT cell development by B7-CD28 interaction: an expanding horizon for costimulation.

P2860

Q24604308-E2361E38-3519-4F66-9568-B10A0B027DD1 Q24648939-F3644BF0-D90B-4167-BAC6-5A75CA556899 Q24650707-B5D50806-619F-4BD9-B327-353CB234A8A0 Q24650966-601A16CA-2876-4700-89F9-2EDB312E31F1 Q24806047-1B76575D-B65E-4EBB-95F4-B08BD3388EA5 Q26766141-0A5BC4B4-2DB0-468D-93A5-BBFD51ABAA1A Q26768699-5C550AC1-41CA-4DF0-8D28-98AF9A71218B Q26773074-AC34A49A-DD97-45A3-8279-2B8B9525744E Q26782520-30F62A1E-5187-48EF-B35F-C968A2E1928F Q26796132-DB40CD00-2171-4509-AB70-FB9380F5F286 Q26797347-C4ED1A6D-5706-4EA0-A22F-2133FD7BD1B7 Q26799999-A551CE57-A7A1-46C1-8776-A108815E6374 Q26825059-849D57D3-C090-4886-B414-70837D51E643 Q26825078-5D4EFB05-297A-458F-BB3A-5C9BDEB4AB28 Q26863207-DEF5B09E-2D9A-4E2A-B4BD-1645766AA673 Q26865391-F4A46266-01F7-4BAF-B88C-221CEE9B4B9B Q26866223-FA7E8C6F-4F97-4193-B9F9-0BC6BE2C2A3F Q27023425-98BF25E7-1F45-4590-A278-C69C47900C06 Q27318814-7687847D-9E55-479B-8424-53443903292D Q27646525-4748F781-948C-4F4D-9318-282468F2A5BD Q27658388-7689A07F-5ACF-4FD7-A0F4-AD58BCDBE034 Q27667168-A5C6323F-4E44-42C3-8D16-CD224210A882 Q27667172-AA32AF4A-25AF-4314-8712-38D1068C6FCC Q27667243-3A06083B-1BBF-47D7-8209-4BB0CB9F5EC8 Q27680179-AF45AD99-6DDF-4832-8E32-232BA229DCCF Q27684762-22FEF6C1-3D89-4279-BBE4-5784C3123D1E Q27686847-E430EF6F-8F2D-4227-85FC-59C381CD2138 Q28081530-036112F9-5515-4EBC-ADDF-52CA01B806E5 Q28260601-6D0DF78E-03E7-4EF8-963C-E1036BD140E6 Q28294740-B4D0A786-4193-4F77-9F86-9BEE8FD27F42 Q28593372-CE918A47-8BC4-40F5-BB9D-A5B04AAE682A Q28743012-CDA68E82-49A5-4949-B884-0732321DA08A Q30009848-11F74BF1-2CFC-45C6-A223-1A62B074EB1B Q30416325-A70306D2-71F4-45AF-BEFE-26A0DACC9244 Q30421670-1C6780D5-BF11-462D-BEBA-06C2F6559518 Q30426423-248B1C5C-A085-4740-AE33-F496E398F15F Q30432794-5426EE46-EB96-451D-90E4-34D22C1F4BE2 Q30433085-F9D068DB-8C4D-4FC1-8D39-11D82F944F32 Q30664500-55F62A46-2AA6-4CD5-B536-04BD8A5F5439 Q30845162-B4EFD962-20B6-48BB-8FBA-38EFB5D27F9E

P2860

Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers

http://www.wikidata.org/entity/Q36368804

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年学术文章

@wuu

2000年学术文章

@zh-cn

2000年学术文章

@zh-hans

2000年学术文章

@zh-my

2000年学术文章

@zh-sg

2000年學術文章

@yue

2000年學術文章

@zh

2000年學術文章

@zh-hant

name

Tracking the response of natur ...... d antigen using CD1d tetramers

@ast

Tracking the response of natur ...... d antigen using CD1d tetramers

@en

type

label

Tracking the response of natur ...... d antigen using CD1d tetramers

@ast

Tracking the response of natur ...... d antigen using CD1d tetramers

@en

prefLabel

Tracking the response of natur ...... d antigen using CD1d tetramers

@ast

Tracking the response of natur ...... d antigen using CD1d tetramers

@en

P1433

Q36368804-0B2AB3FE-8AE4-44CB-9497-88CF9C1DE335

P1476

Q36368804-426C8E75-17D0-4961-9505-2709BD0FA1E9

P2093

Q36368804-03CB7496-DAD7-44D5-8681-38B14ACF9FBA

Q36368804-4A57C658-5C97-4EEC-A3BF-B8C585E35480

Q36368804-4F88EF76-0291-487A-9280-18140CFAD4FD

Q36368804-6D38DAD1-D2FA-42E3-B4EF-3B86D0C131A8

Q36368804-828B4C58-9197-457C-8275-B9B2B48B3E02

Q36368804-8C11373B-ECFA-4116-95EA-A5FE5BE4A656

Q36368804-E9754310-1848-430A-A927-5741F96EBAF0

Q36368804-F4876B5A-1815-4CF8-BD0E-99B917E3BA8B

P2860

Q36368804-0135BE74-52EB-4C7E-9691-B08E254857D4

Q36368804-013C9382-6FDB-47C8-96E4-D4EECD7CFEED

Q36368804-014AFA3C-6033-4DB4-A325-3746958220E8

Q36368804-02A6C366-93DD-4046-9647-B671BBCEC6CA

Q36368804-05727903-9427-4B7F-A409-74B1DC6E0B8B

Q36368804-1B3C98C8-D0D0-4808-8D65-090DA8135132

Q36368804-217D79C4-55BD-450E-A14A-78C85D36CE74

Q36368804-26CC4F9F-BE12-4579-A12C-2D72BB58F89D

Q36368804-2F6B6BA1-71A8-4F5E-ACF9-7DFA677948A3

Q36368804-3677B550-1115-4120-B26E-55C37C6CC9BE

P304

Q36368804-7076D657-4F4E-4ECC-882B-747349E8E14B

P31

Q36368804-186F7E6C-0406-485B-8BA7-A654AFFE35AF

P356

Q36368804-E332130C-A3EA-42B3-A84F-3398822666E1

P407

Q36368804-15F0727A-AFA9-4016-AC15-F85F18F20F7D

P433

Q36368804-B6FBD94D-F946-4947-B835-EF69B1BD74E3

P478

Q36368804-68F0EF5E-7712-4993-AAF2-31251832BF4D

P577

Q36368804-AD45C064-AC15-431F-83B2-52099CE11C71

P5875

Q36368804-B0351E8C-E6A1-47A4-B9F3-1C8305E70E09

P698

Q36368804-D7C4B98E-CD42-464B-9D75-660ABC572B2C

P932

Q36368804-714BB575-DD91-46BA-8EE7-5E2BCED38A8B

P356

P1433

Journal of Experimental Medicine

P1476

Tracking the response of natur ...... d antigen using CD1d tetramers

@en

P2093

C R Wang

http://www.w3.org/2001/XMLSchema#string

J L Matsuda

http://www.w3.org/2001/XMLSchema#string

L Gapin

http://www.w3.org/2001/XMLSchema#string

M Kronenberg

http://www.w3.org/2001/XMLSchema#string

M Taniguchi

http://www.w3.org/2001/XMLSchema#string

O V Naidenko

http://www.w3.org/2001/XMLSchema#string

T Nakayama

http://www.w3.org/2001/XMLSchema#string

Y Koezuka

http://www.w3.org/2001/XMLSchema#string

P2860

Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules

Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b)

Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

Phenotypic analysis of antigen-specific T lymphocytes

Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol.

Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells.

CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice

A role for CD4+ NK1.1+ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infection.

P304

741-754

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.192.5.741

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

192

http://www.w3.org/2001/XMLSchema#string

P577

2000-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12348233

http://www.w3.org/2001/XMLSchema#string

P698

10974039

http://www.w3.org/2001/XMLSchema#string

P932

2193268

http://www.w3.org/2001/XMLSchema#string